Hester Biosciences Limited has informed the Exchange regarding Cessation of Mr. Divyesh Maru as Chief Executive Officer of the company w.e.f. November 13, 2025.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the stock exchange that Mr. Divyesh Maru has ceased to be the Chief Executive Officer of the company with effect from November 13, 2025. The announcement does not specify the reason for his exit or mention an immediate successor. Mr. Maru held one of the top leadership roles at the company, which is primarily engaged in animal vaccines and healthcare. No additional details about transition plans or interim arrangements have been disclosed in this filing.
A sudden top leadership exit without a named successor may raise short-term uncertainty among investors about the company's strategic direction and operational continuity. Shareholders should watch for follow-up disclosures on a permanent CEO appointment and any related reasons for the departure.